Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
6.06
0.00 (0.00%)
Nov 12, 2025, 4:00 PM EST - Market closed
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $155.23 million as of November 12, 2025. Its market cap has decreased by -5.00% in one year.
Market Cap
155.23M
Enterprise Value
119.78M
1-Year Change
-5.00%
Ranking
Category
Stock Price
$6.06
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $155.23M, an increase of 167.61%. That is a compound annual growth rate of 29.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 155.23M | 48.50% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 866.56B |
| Johnson & Johnson | 453.07B |
| AbbVie | 386.95B |
| UnitedHealth Group | 289.06B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.29B |
| Abbott Laboratories | 219.10B |
| Thermo Fisher Scientific | 216.97B |